Day: September 29, 2020

LADOT and Conduent recognized for parking initiatives benefiting low-income and economically disadvantaged motoristsFor the third consecutive year, a Conduent-supported program received the prestigious award for innovative programs in parking managementFLORHAM PARK, N.J., Sept. 29, 2020 (GLOBE NEWSWIRE) — The Los Angeles Department of Transportation (LADOT) has been named the 2020 Innovative Organization of the Year by the National Parking Association for its work with Conduent Transportation, a unit of business process services and solutions company Conduent Incorporated (Nasdaq: CNDT). The award honors best practices, innovation and leadership within the parking industry.The association recognized LADOT for parking initiatives benefiting low-income and economically disadvantaged motorists, including those affected by the COVID-19...

AUSTIN, Texas, Sept. 29, 2020 (GLOBE NEWSWIRE) — AYRO, Inc. (NASDAQ: AYRO), an engineer and manufacturer of light-duty, urban and short-haul electric vehicles (EVs), and Karma Automotive’s Innovation and Customization Center (KICC), today announced the formation of a strategic manufacturing, engineering and design partnership.This partnership will utilize Karma’s state-of-the-art Innovation and Customization Center, Karma Engineering resources and the Karma Design Studio to provide expertise and contract manufacturing services for the next generation of AYRO’s light-duty vehicles. KICC will also provide strategic engineering and development services for electrified solutions within the fast-growing delivery and microdistribution markets.By combining AYRO’s end-user, market and engineering expertise with KICC’s manufacturing capabilities,...

TORONTO, Sept. 29, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“U.S. FDA”) Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19. The Company has selected and finalized with five clinical sites in Florida, Texas and California for enrollment of patients in the Phase 3 clinical study, and is finalizing agreements with an additional ten clinical sites in these states including Arizona and Ohio where patient enrollment should start in October within these other locations.“We have made significant progress...

SOUTH SAN FRANCISCO, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced that it will participate at the following virtual investor conference:Jefferies Virtual Cell Therapy SummitDate: Tuesday, October 6, 2020Fireside chat presentation: 4:30 p.m. ETA live audio webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com. A replay of the webcast will be archived on the website for approximately four weeks.About NkartaNkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering...

Aarhus, den 29. september 2020NASDAQ OMX Copenhagen A/SMeddelelse nr. 08 /2020Indkaldelse til ordinær generalforsamlingAGF A/S, CVR-nr. 83 83 99 10, afholder generalforsamlingtorsdag den 22. oktober 2020 kl. 16.00I Ceres Park, PR electronics Lounge, Stadion Allé 70, 8000 Aarhus CDagsorden:Bestyrelsens beretning om selskabets virksomhed i det forløbne årFremlæggelse af revideret årsrapportGodkendelse af årsrapporten, herunder beslutning om anvendelse af overskud eller dækning af tab i henhold til den godkendte årsrapport, samt meddelelse af decharge for direktion og bestyrelseBehandling af forslag fra aktionærer og bestyrelseValg af medlemmer til bestyrelsenValg af revisorEventueltAd 4:Der er fremkommet forslag fra selskabets bestyrelse om vedtagelse af den som bilag 1 vedlagte vederlagspolitik for AGF A/S Koncernen.Ad 5:Bestyrelsen foreslår...

VANCOUVER, British Columbia, Sept. 29, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has now enrolled 100 patients, which is two thirds of its enrollment target, for its multinational Phase 2b/3 human study of NP-120 (Ifenprodil) for the treatment of COVID-19.The Company has projected that the study will be completed in November 2020 with a planned data readout before the end of Q4, 2020.Phase 2b/3 Study Protocol SummaryThe Company’s multinational Phase 2b/3 human trial for COVID-19 is entitled, “A Randomized Open Label Phase 2b/3 Study of the Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patients with Confirmed COVID-19 Disease.”The...

MCCARRAN, Nev., Sept. 29, 2020 (GLOBE NEWSWIRE) — Aqua Metals, Inc. (NASDAQ: AQMS) (“Aqua Metals” or the “Company”), which is reinventing lead recycling with its AquaRefining™ technology, announced today it has received an additional progress payment of $1.5 million from its insurance provider. The Company has now collected a total of $21.8 million of insurance proceeds related to the November 2019 fire event. Of the total proceeds received to date, $14.2 million have been paid to Aqua Metals and the balance of $7.6 million have been allocated to the retirement of the Veritex Bank loan.    Including this payment, Layer 3 has now paid out $9.3 million, which is approximately 75% of the total Layer 3 insurance coverage amount of $12.5 million. Layer 4, for which the Company previously submitted property, casualty and business interruption...

NORWALK, Conn., Sept. 29, 2020 (GLOBE NEWSWIRE) — FactSet (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry-leading service, announced that it has launched content and analytics for Danish covered bonds across its distribution channels, including the FactSet workstation. The company is working with Scanrate, a leading provider of fixed income software, models, and data for the Danish bond market, to deliver increased coverage of the Danish market.“Denmark is one of the most secure property markets in the world, and we are already seeing demand from fixed income clients looking for more flexible assets in the hunt for yield,” said Carl Cedstrand, Vice President and Regional Director, UK and Nordics, FactSet. “We are providing a unique content set thanks to our work...